Bank of Montreal’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-54,069
| Closed | -$9.55M | – | 3781 |
|
|
2021
Q3 | $9.55M | Sell |
54,069
-143,740
| -73% | -$25.4M | ﹤0.01% | 1216 |
|
|
2021
Q2 | $25.1M | Buy |
197,809
+195,265
| +7,676% | +$24.8M | 0.01% | 745 |
|
|
2021
Q1 | $329K | Buy |
2,544
+449
| +21% | +$58.1K | ﹤0.01% | 2528 |
|
|
2020
Q4 | $245K | Sell |
2,095
-16
| -0.8% | -$1.87K | ﹤0.01% | 2681 |
|
|
2020
Q3 | $232K | Sell |
2,111
-394
| -16% | -$43.3K | ﹤0.01% | 2313 |
|
|
2020
Q2 | $252K | Buy |
2,505
+151
| +6% | +$15.2K | ﹤0.01% | 2274 |
|
|
2020
Q1 | $197K | Sell |
2,354
-6,246
| -73% | -$523K | ﹤0.01% | 2075 |
|
|
2019
Q4 | $457K | Buy |
8,600
+4,339
| +102% | +$231K | ﹤0.01% | 2284 |
|
|
2019
Q3 | $168K | Buy |
4,261
+339
| +9% | +$13.4K | ﹤0.01% | 2561 |
|
|
2019
Q2 | $161K | Buy |
3,922
+3,830
| +4,163% | +$157K | ﹤0.01% | 2623 |
|
|
2019
Q1 | $4K | Sell |
92
-1,592
| -95% | -$69.2K | ﹤0.01% | 3665 |
|
|
2018
Q4 | $73K | Sell |
1,684
-207
| -11% | -$8.97K | ﹤0.01% | 2792 |
|
|
2018
Q3 | $108K | Buy |
1,891
+1,290
| +215% | +$73.7K | ﹤0.01% | 2766 |
|
|
2018
Q2 | $29K | Buy |
601
+275
| +84% | +$13.3K | ﹤0.01% | 3295 |
|
|
2018
Q1 | $13K | Sell |
326
-1,144
| -78% | -$45.6K | ﹤0.01% | 3408 |
|
|
2017
Q4 | $62K | Hold |
1,470
| – | – | ﹤0.01% | 2893 |
|
|
2017
Q3 | $55K | Sell |
1,470
-7,501
| -84% | -$281K | ﹤0.01% | 2925 |
|
|
2017
Q2 | $273K | Hold |
8,971
| – | – | ﹤0.01% | 2279 |
|
|
2017
Q1 | $237K | Buy |
+8,971
| New | +$237K | ﹤0.01% | 2183 |
|
|
2015
Q1 | – | Sell |
-6,700
| Closed | -$261K | – | 3840 |
|
|
2014
Q4 | $261K | Buy |
+6,700
| New | +$261K | ﹤0.01% | 2025 |
|
|
2014
Q3 | – | Sell |
-180
| Closed | -$6K | – | 4000 |
|
|
2014
Q2 | $6K | Buy |
+180
| New | +$6K | ﹤0.01% | 3695 |
|